Literature DB >> 16799779

The role of the determination of the CD20 antigen through quantitative flow cytometry in complex cases of rheumatoid arthritis treated with anti-TNF-alpha.

A Hobi1, T Bihl, B Fellay, M Waldburger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16799779     DOI： 10.1007/s00296-006-0139-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  3 in total

1.  CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59.

Authors:  J Golay; M Lazzari; V Facchinetti; S Bernasconi; G Borleri; T Barbui; A Rambaldi; M Introna
Journal:  Blood       Date:  2001-12-01       Impact factor: 22.113

2.  Levels of expression of CD19 and CD20 in chronic B cell leukaemias.

Authors:  L Ginaldi; M De Martinis; E Matutes; N Farahat; R Morilla; D Catovsky
Journal:  J Clin Pathol       Date:  1998-05       Impact factor: 3.411

3.  Panel discussion on B cells and rituximab: mechanistic aspects, efficacy and safety in rheumatoid arthritis and non-Hodgkin's lymphoma.

Authors:  G S Panayi; J D Hainsworth; R J Looney; E C Keystone
Journal:  Rheumatology (Oxford)       Date:  2005-05       Impact factor: 7.580
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.